“…Novel technology improvements enable better biological characterization and molecular understanding of intratumoral heterogeneity of breast cancer subgroups. Zsuzsana Bago-Horvath [1] summarizes the progress of translational studies presented at the 40th San Antonio Breast Cancer Symposium 2017.…”